Business Description
Herantis Pharma is a Finnish drug development company focused on finding new treatments for Parkinson's disease and similar conditions. Its most advanced program centers on HER-096, a lab-designed molecule inspired by a naturally occurring brain protein, which is currently being tested in human clinical trials. The company was founded in 2008 and operates out of Espoo, Finland.
